Ken Griffin Olema Pharmaceuticals, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 6,300 shares of OLMA stock, worth $63,755. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,300

Previous 32,200 80.43%

Holding current value

$63,755

Previous $348,000 78.45%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.41 - $16.46 $11.7 Million - $18.4 Million	1,120,492 Added 847.23%	1,252,745 $15 Million
Q2 2024 Aug 14, 2024	SELL	$8.73 - $13.99 $5.66 Million - $9.07 Million	-648,407 Reduced 83.06%	132,253 $1.43 Million
Q1 2024 May 15, 2024	BUY	$10.95 - $16.62 $5.44 Million - $8.26 Million	496,708 Added 174.93%	780,660 $8.84 Million
Q4 2023 Feb 14, 2024	SELL	$10.53 - $17.14 $1.63 Million - $2.66 Million	-154,952 Reduced 35.3%	283,952 $3.98 Million
Q3 2023 Nov 14, 2023	SELL	$8.19 - $12.98 $1.62 Million - $2.56 Million	-197,571 Reduced 31.04%	438,904 $5.42 Million
Q2 2023 Aug 14, 2023	SELL	$3.22 - $9.65 $1.91 Million - $5.73 Million	-594,041 Reduced 48.28%	636,475 $5.75 Million
Q1 2023 May 15, 2023	BUY	$2.55 - $4.97 $13,683 - $26,669	5,366 Added 0.44%	1,230,516 $4.27 Million
Q4 2022 Feb 14, 2023	SELL	$2.27 - $3.76 $63,087 - $104,497	-27,792 Reduced 2.22%	1,225,150 $3 Million
Q3 2022 Nov 14, 2022	SELL	$2.72 - $5.88 $620,902 - $1.34 Million	-228,273 Reduced 15.41%	1,252,942 $3.46 Million
Q2 2022 Aug 15, 2022	BUY	$2.04 - $4.61 $447,882 - $1.01 Million	219,550 Added 17.4%	1,481,215 $6.03 Million
Q1 2022 May 16, 2022	SELL	$3.89 - $9.43 $641,254 - $1.55 Million	-164,847 Reduced 11.56%	1,261,665 $5.37 Million
Q4 2021 Feb 14, 2022	SELL	$8.75 - $30.71 $442,251 - $1.55 Million	-50,543 Reduced 3.42%	1,426,512 $13.4 Million
Q3 2021 Nov 15, 2021	BUY	$22.96 - $30.13 $931,624 - $1.22 Million	40,576 Added 2.82%	1,477,055 $40.7 Million
Q2 2021 Aug 16, 2021	BUY	$21.15 - $36.14 $35,595 - $60,823	1,683 Added 0.12%	1,436,479 $40.2 Million
Q4 2020 Feb 16, 2021	BUY	$37.09 - $54.5 $53.2 Million - $78.2 Million	1,434,796 New	1,434,796 $69 Million

Others Institutions Holding OLMA

# of Institutions

136

Shares Held

58.7M

Call Options Held

141K

Put Options Held

23.1K

View Full List

About Olema Pharmaceuticals, Inc.

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $409M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

More about OLMA

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account